The use of proceeds will be allocated to repayment of CD#1 in full at a 50% discount to face value ($1,250,000) and general working capital in support of the Company's continuing operational expenses, ...

"Our technique involves the use of a flush circuit to oxygenate 2 liters of a cold preservation solution consisting of packed red cells, del Nido cardioplegia, and other additives. The solution is ...

With India witnessing a quiet explosion in heart failure cases, many striking working-age adults, STAR Hospitals has launched ...

With India witnessing a quiet explosion in heart failure cases—many striking working-age adults—STAR Hospitals has launched the STAR Heart Failure Clinic in Hyderabad, an initiative poised to tackle ...

However, Hemostemix's ACP-01 stands apart, due to its specific molecular characteristics and its ability to precisely target the root causes of non ischemic dilated cardiomyopathy (DCM ...

Next Step: Treatment of nao-option patients in Florida Building on Florida's new law that permits the use of non FDA approved stem cell treatments and Hemostemix's scientific findings, the Company is ...

(TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), a clinical-stage biotechnology company focused on autologous stem cell therapies for cardiovascular diseases, is pleased to announce that Florida Senate Bill ...

The relationship between genetic variants and the risk of late-onset cardiomyopathy remains poorly understood in survivors of childhood cancer despite being otherwise well established.

Variants in the non-ischemic dilated cardiomyopathy group were found in the TTN, FLNC, LMNA, MYH7, and RBM20 genes. Conclusions: Patients with ischemic dilated cardiomyopathy undergoing heart ...

A new study led by researchers at The Ohio State University Wexner Medical Center and College of Medicine found that heavy alcohol use does not directly cause dilated cardiomyopathy (DCM), an ...

ACP-01 is safe, clinically relevant and statistically significant treatment for peripheral arterial disease, chronic limb threatening ischemia, non ischemic dilated cardiomyopathy, ischemic ...

Myeloperoxidase Inhibition in Patients With Ischemic or Non-Ischemic Cardiomyopathy and Heart Failure With Reduced Ejection Fraction (MYSTERY-HF) ...